LakeShore Biopharma Co., Ltd (LSBCF)
OTCMKTS
· Delayed Price · Currency is USD
0.0278
0.00 (0.00%)
Apr 28, 2026, 4:00 PM EST
LakeShore Biopharma Market Cap
LakeShore Biopharma has a market cap or net worth of $1.15 million as of April 29, 2026. Its market cap has decreased by -97.46% in one year.
Market Cap
1.15M
Enterprise Value
54.38M
Revenue
84.75M
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.03
Market Cap Chart
Since August 5, 2021, LakeShore Biopharma's market cap has decreased from 227.76M to 1.15M, a decrease of -99.50%. That is a compound annual growth rate of -67.34%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 27, 2026 | 1.15M | -96.69% |
| Dec 31, 2025 | 34.62M | -47.56% |
| Dec 31, 2024 | 66.02M | 38.83% |
| Dec 29, 2023 | 47.55M | -80.26% |
| Dec 30, 2022 | 240.85M | 3.14% |
| Dec 29, 2021 | 233.52M | 2.53% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Evofem Biosciences | 1.15M |
| Abpro Holdings | 1.17M |
| CERo Therapeutics Holdings | 1.18M |
| GB Sciences | 1.06M |
| Eastgate Biotech | 1.06M |
| Lyra Therapeutics | 1.26M |
| Windtree Therapeutics | 1.03M |
| Sirona Biochem | 1.35M |